article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Subscribe below and stay informed in this critical field, and you’ll be equipped to deliver top-tier care in managing lipid disorders and cognitive health for improved patient outcomes.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life.

article thumbnail

Harnessing Telehealth and Home Blood Pressure Monitoring to Improve Hypertension Care

Cardiometabolic Health Congress

Whether it’s providing tech support, advocating for EHR integration, or offering video visits, we can leverage these advancements to improve patient outcomes. Why Telehealth is Essential for Hypertension For patients with hypertension, managing blood pressure outside of the office is crucial.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

The FDA decision is based on the results of the landmark SELECT phase 3 cardiovascular outcomes trial that examined the effect of adding Wegovy 2.4 1,2 The primary composite outcome occurred in 6.5% 1,2 The primary composite outcome occurred in 6.5% Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

Obesity 111